购物车
- 全部删除
您的购物车当前为空
PACAP (1-27), human, ovine, rat acetate
很棒产品编号 TP1070L
别名 PACAP 1-27 acetate, PACAP (1-27), human, ovine, rat acetate(127317-03-7 free base)
PACAP (1-27), human, ovine, rat acetate (PACAP 1-27 acetate)(127317-03-7 free base) 是一种新的神经肽，最初从牛下丘脑中分离出来，也存在于人和大鼠中。
PACAP (1-27), human, ovine, rat acetate
很棒 纯度: 98%
产品编号 TP1070L 别名 PACAP 1-27 acetate, PACAP (1-27), human, ovine, rat acetate(127317-03-7 free base)
PACAP (1-27), human, ovine, rat acetate (PACAP 1-27 acetate)(127317-03-7 free base) 是一种新的神经肽，最初从牛下丘脑中分离出来，也存在于人和大鼠中。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,470 | 现货 | |
| 5 mg | ¥ 3,680 | 现货 | |
| 10 mg | ¥ 5,330 | 现货 | |
| 25 mg | ¥ 8,270 | 现货 | |
| 50 mg | ¥ 10,900 | 现货 | |
| 100 mg | ¥ 14,800 | 现货 |
大包装 & 定制
加入购物车
实验操作小课堂
查看更多 与"PACAP (1-27), human, ovine, rat acetate"相关的抑制剂
PACAP-38 (31-38), human, mouse, rat acetate
PACAP-38 (31-38), human, mouse, rat acetate(138764-85-9 Free base)
TP1618L
PACAP-38 (31-38), human, mouse, rat acetate 是 PAC1 受体的激活剂。PACAP-38 (31-38), human, mouse, rat acetate 对交感神经元 NPY 和儿茶酚胺的产生具有强效、有效和持续的刺激作用，可用于神经营养和神经保护研究。
- ¥ 1310
规格
数量
PA-8
T41005878437-15-1
PA-8是一种小分子的的 PACAP I 型(PAC1)受体拮抗剂，有 选择性、有效性和口服活性。PA-8抑制PACAP 诱导的CREB 在PAC1-受体上的磷酸化，但对VPAC11或VPAC2受体无抑制作用。PA-8也抑制pacap 诱导的体外cAMP 水平升高(IC50 = 2 nM)和体内鞘内注射后pacap 诱导的厌恶反应和机械异位性痛。
- ¥ 185
规格
数量
PACAP 1-38 acetate
TP1878L
PACAP 1-38 acetate 是一种垂体腺苷酸环化酶激活多肽 (PACAP) 类似物。它与 PACAP I 型受体 (IC50 = 4 nM) 和 PACAP II 型 VIP2 受体 (IC50 = 1 nM) 结合，但不与 PACAP II 型 VIP1 受体结合。
- ¥ 1390
规格
数量
PACAP (1-38), human, ovine, rat
腺苷酸环化酶激活肽-38(抗原), Pituitary Adenylate Cyclase Activating Polypeptide 38, PACAP 1-38
TP1878137061-48-4
PACAP (1-38), human, ovine, rat (Pituitary Adenylate Cyclase Activating Polypeptide 38) 是含有 38 个氨基酸残基的神经肽。它能够结合 PACAP I 型受体(IC50:4 nM)、PACAP II 型受体 VIP1(IC50:2 nM)、PACAP II 型受体 VIP2(IC50:1 nM)。
- ¥ 1342
规格
数量
PAC1R antagonist 1
T781052305204-24-2
PAC1R antagonist 1为一种具有口服活性的 PAC1 受体拮抗剂，可抑制由垂体腺苷酸环化酶激活多肽（PACAP）及神经损伤所诱导的异常性疼痛，可用于研究肿瘤和与免疫相关的疾病。
- ¥ 939
规格
数量
PACAP (6-38), human, ovine, rat acetate
TP1722L
PACAP (6-38), human, ovine, rat acetate 是一种有效的 PACAP 受体拮抗剂。PACAP (6-38) 作用于 PACAP I 型受体，PACAP II 型受体 VIP1 和 PACAP II 型受体 VIP2，IC50 分别为 30 nM，600 nM 和 40 nM。
- ¥ 833
规格
数量
PACAP-related Peptide (human) (trifluoroacetate salt)
T36428
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adenylate cyclase-activating polypeptide . It is expressed in normal human pancreas and adrenal gland tissue and in some tumors that produce vasoactive intestinal peptide (VIP). PRP (1-29) is secreted by CHO-K1 cells that express human recombinant preproPACAP.
- ¥ 6370
规格
数量
PACAP (6-27) (human, chicken, mouse, ovine, porcine, rat) (trifluoroacetate salt)
T36427
Pituitary adenylate cyclase-activating peptide (PACAP) (6-27) is a PACAP receptor antagonist with IC50 values of 1,500, 600, and 300 nM, respectively, for rat PAC1, rat VPAC1, and human VPAC2 recombinant receptors expressed in CHO cells. It binds to PACAP receptors on SH-SY5Y and SK-N-MC human neuroblastoma and T47D human breast cancer cells (IC50s = 24.5, 106, and 105 nM, respectively) and inhibits cAMP accumulation induced by PACAP (1-38) (Kis = 457, 102, and 283 nM, respectively, in SH-SY5Y, SK-N-MC, and T47D cells). In vivo, in newborn pigs, PACAP (6-27) (10 μM) inhibits vasodilation of pial arterioles induced by PACAP (1-27) and PACAP (1-38) . It also inhibits PACAP (1-27)-stimulated increases in plasma insulin and glucagon levels and pancreatic venous blood flow in dogs when administered locally to the pancreas at a dose of 500 μg.
- ¥ 2970
规格
数量
PACAP-related Peptide (rat) (trifluoroacetate salt)
T37435
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , glucagon , glucagon-like peptide-1 , GLP-2 , and pituitary adenylate cyclase-activating polypeptide . It is expressed in rat hypothalamus as well as within the nerves of the median eminence, the anterior pituitary, bed nucleus of the stria terminalis, cerebellum, cerebral cortex, and amygdala. PRP is also expressed in vaginal, uterine cervical, uterine horn, fallopian tube, and ovarian tissues from the rat female genital tract and is present in extracts of male testis tissue.
- ¥ 4390
规格
数量
选择批次:
纯度:98%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。产品介绍
生物活性
化学信息
| 产品描述 | PACAP (1-27), human, ovine, rat acetate (PACAP 1-27 acetate) is a novel neuropeptides originally isolated from bovine hypothalamus, also found in humans and rats. |
| 体外活性 | 通过对I-monoiodinated PACAP (1-27), human, ovine, rat进行放射配体受体结合实验，确认AR4-2J细胞表面存在PAC受体，因为PACAP (1-27), human, ovine, rat和PACAP(1–38)以相同的效力（Kd值为1-2 nM）置换放射配体的结合，而血管活性肠肽(VIP)的效力则低1000倍。PACAP (1-27), human, ovine, rat对VIP-氨基酸替换表现出明显更高的敏感性。在AR4-2J细胞中，PACAP (1-27), human, ovine, rat展现出促进IP3和cAMP生成的效能和结合亲和力。 |
| 体内活性 | 垂体腺苷酸环化酶激活多肽(PACAP (1-27), human, ovine, rat)对麻醉、通气的豚鼠总肺阻力(RL)增加的抑制作用进行了研究，该增加由过敏原或组胺引起。通过静脉输注给予PACAP (1-27), human, ovine, rat（剂量范围0.045-4.5 nmol/kg/min）能剂量依赖性地减少吸入卵清蛋白和组胺引起的RL增加。在最高剂量时，PACAP (1-27), human, ovine, rat完全阻止了由卵清蛋白和组胺引起的RL增加。PACAP (1-27), human, ovine, rat与β2-肾上腺素受体激动剂，沙丁胺醇（剂量范围0.045-4.5 nmol/kg/min）的输注同样抑制RL增加，但沙丁胺醇比PACAP (1-27), human, ovine, rat更能增加心率[3]。 |
| 别名 | PACAP 1-27 acetate, PACAP (1-27), human, ovine, rat acetate(127317-03-7 free base) |
| 分子量 | 3207.71 |
| 分子式 | C144H228N40O41S |
| Smiles | O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCSC)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@H](C(N)=O)CC(C)C)=O)=O)=O)=O)=O)CC1=CC=C(O)C=C1)=O)=O)=O)=O)=O)=O)=O)=O)[C@@H](NC([C@H](CCCNC(N)=N)NC([C@H](CO)NC([C@@H](NC([C@H](CO)NC([C@H](CC(O)=O)NC([C@@]([C@H](O)C)([H])NC([C@@H](NC([C@@]([C@@H](C)CC)([H])NC(CNC([C@H](CC(O)=O)NC([C@H](CO)NC([C@@H](N)CC2=CNC=N2)=O)=O)=O)=O)=O)CC3=CC=CC=C3)=O)=O)=O)=O)CC4=CC=C(O)C=C4)=O)=O)=O)CC5=CC=C(O)C=C5.CC(O)=O |
| 密度 | 1.31g/cm3 |
储存&溶解度
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
| 溶解度信息 | DMSO: 5 mM | |||||||||||||||
溶液配制表 | ||||||||||||||||
| ||||||||||||||||
计算器
体内实验配液计算器
请在以下方框中输入您的动物实验信息后点击计算，可以得到母液配置方法和体内配方的制备方法：
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
剂量转换
对于不同动物的给药剂量换算，您也可以参考 更多
关键词
评论列表
预览
Related Tags: buy PACAP (1-27), human, ovine, rat acetate | purchase PACAP (1-27), human, ovine, rat acetate | PACAP (1-27), human, ovine, rat acetate cost | order PACAP (1-27), human, ovine, rat acetate | PACAP (1-27), human, ovine, rat acetate chemical structure | PACAP (1-27), human, ovine, rat acetate in vivo | PACAP (1-27), human, ovine, rat acetate in vitro | PACAP (1-27), human, ovine, rat acetate formula | PACAP (1-27), human, ovine, rat acetate molecular weight
嗨！很高兴为您提供帮助！
评论内容